CPMD · Cannapharmarx, Inc. · Proposed Sales
$0.00
At close · Oct 20
View the 10-K filed Mar 31, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on current financial projections, the Company does not have sufficient existing cash resources to fund its current operations. Accordingly, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 18, 2026
Customer concentration
— top customer 63% of revenue
One customer — 63% of revenue (the year ended December 31, 2025)
“During the year ended December 31, 2025, the Company also recognized revenue of $861,476 (2024 - $nil) from the sale of cannabis products to a pharmaceutical company based in Germany. This comprised 63% of the revenues generated during the year ended December 31, 2025.”
One customer — 29% of revenue (the year ended December 31, 2025)
“During the year ended December 31, 2025, the Company recognized revenue of $394,633 (2024 - $770,265) from Cantek (Note 12), which was 29% of the total revenue (2024 - 94%).”
Market Cap
$1.42M
Shares
708.69M
Volume · Oct 20
5900
Avg daily vol (3M)
67.59K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Showing 1–2 of 2 filings